(Q38264788)

1 September 2017

1 reference

title

Cyclophosphamide treatment for idiopathic inflammatory myopathies and related interstitial lung disease: a systematic review (English)

1 reference

interstitial lung disease

1 September 2017

1 reference

1 reference

idiopathic inflammatory myopathy

inferred from title

1 reference

Yongpeng Ge

1

1 reference

1 September 2017

Qinglin Peng

2

1 reference

1 September 2017

Sigong Zhang

3

1 reference

1 September 2017

Hang Zhou

4

1 reference

1 September 2017

Xin Lu

5

1 reference

1 September 2017

Guochun Wang

6

1 reference

1 September 2017

publication date

1 November 2014

1 reference

1 September 2017

published in

Clinical Rheumatology

1 reference

1 September 2017

volume

34

1 reference

1 September 2017

issue

1

1 reference

1 September 2017

page(s)

99-105

1 reference

Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years?

1 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10067-014-2803-Z

Interstitial lung disease and idiopathic inflammatory myopathies: progress and pitfalls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-014-2803-Z

Polymyositis and dermatomyositis (first of two parts)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-014-2803-Z

Interstitial lung disease in polymyositis and dermatomyositis: Clinical course and response to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-014-2803-Z

Intravenous cyclophosphamide pulse therapy in juvenile dermatomyositis. A review of efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-014-2803-Z

Intravenous cyclophosphamide therapy for progressive interstitial pneumonia in patients with polymyositis/dermatomyositis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-014-2803-Z

A retrospective review of clinical features and treatment outcomes in steroid-resistant interstitial lung disease from polymyositis/dermatomyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-014-2803-Z

Interstitial lung disease outcomes by high-resolution computed tomography (HRCT) in Anti-Jo1 antibody-positive polymyositis patients: a single centre study and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-014-2803-Z

The value of pulse cyclophosphamide in ANCA-associated vasculitis: meta-analysis and critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-014-2803-Z

Combination therapy with corticosteroids, cyclosporin A, and intravenous pulse cyclophosphamide for acute/subacute interstitial pneumonia in patients with dermatomyositis

21 January 2018

1 reference

12 December 2020

American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS)

1 reference

12 December 2020

Clinico-pathological manifestations in interstitial lung diseases associated with polymyositis-dermatomyositis

1 reference

12 December 2020

Interstitial lung disease due to polymyositis or dermatomyositis: effect of a 6-month course of i.v. pulse cyclophosphamide

1 reference

12 December 2020

Predicting factors of interstitial lung disease in dermatomyositis and polymyositis

1 reference

12 December 2020

Short-term and long-term outcomes of interstitial lung disease in polymyositis and dermatomyositis: a series of 107 patients

1 reference

12 December 2020

The failure of intravenous cyclophosphamide therapy in refractory idiopathic inflammatory myopathy

1 reference

12 December 2020

Efficacy and limitations of pulse cyclophosphamide therapy in polymyositis and dermatomyositis

1 reference

12 December 2020

Clinical study of 10 cases of acute or subacute interstitial pneumonia associated with dermatomyositis

1 reference

12 December 2020

10.1007/S10067-014-2803-Z

Identifiers

DOI

1 reference

1 September 2017

1 reference